California Cancer Reporting System Standards, Volume III
IF730: Hormone 2, Date of DX, Site, Hist (CER)
Eureka Tumor Level
Eureka Admission Level
Hormone 2 NSC Number [NAACCR #9862]
Date of Diagnosis [NAACCR #390]
Primary Site [NAACCR #400]
Histologic Type ICD-O-3 [NAACCR #522]
County at DX [NAACCR #90]
If year of Date of Diagnosis = 2011 andpatient is Region 3 resident for this site/hist and Primary Site = [value] and Histologic Type ICD-O-3 = [value], Hormone 2 cannot be blank.
This edit verifies that Hormone 2 NSC Number is populated for Breast, Colorectal, and CML cases diagnosed in 2011 diagnosed that are Region 3 resident cases
This edit is skipped if any of the following conditions are true:
Year of Date of Diagnosis is not 2011
Case is not one of the following site/histologies
Breast (Primary Site = C500-C509 and Histologic Type ICD-O-3 = 8000-9044, 9060-9136, or 9141-9582)
Colorectal (Primary Site = C180-C189, C199, or C209 and Histologic Type ICD-O-3 = 8000-9044, 9060-9136, or 9141-9582)
Chronic Myeloid Leukemia (Primary Site = C421 and Histologic Type ICD-O-3 = 9863, 9875, 9876, 9945, or 9946)
Hormone 2 NSC Number cannot be blank
8/2011 |
This item added for 2011 as part of the CER project. Region 3 criteria added to the CER edit. |
May 2013 |
Retired upon completion of the CER project. |